IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 5280 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’
Yoshiaki Takahashi,Masayuki Igarashi
The Journal of Antibiotics.2018;71(1)4
[DOI]
2Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives
Elliasu Y. Salifu,Clement Agoni,Fisayo A. Olotu,Mahmoud E.S. Soliman
Computational Biology and Chemistry.2020;85(1)107204
[DOI]
3Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives
M. Neethi Chandra
Computational Biology and Chemistry.2021;85(1)47
[DOI]
4Safety, efficacy, and serum concentration monitoring of bedaquiline in Chinese patients with multidrug-resistant tuberculosis
Jinmeng Li,Gaoyi Yang,Qingshan Cai,Yu Wang,Yingying Xu,Ruoying Zhang,Yazhen Lang,Xinjun Cai
International Journal of Infectious Diseases.2021;110(1)179
[DOI]
5Mycobacterial tryptophan biosynthesis: A promising target for tuberculosis drug development?
Sara Consalvi,Cristina Scarpecci,Mariangela Biava,Giovanna Poce
Bioorganic & Medicinal Chemistry Letters.2019;29(23)126731
[DOI]
6The Emergence of Phenolic Glycans as Virulence Factors in Mycobacterium tuberculosis
Danielle D. Barnes,Mimmi L. E. Lundahl,Ed C. Lavelle,Eoin M. Scanlan
ACS Chemical Biology.2017;12(8)1969
[DOI]
7Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids
Alka Pawar,Prakash Jha,Madhu Chopra,Uma Chaudhry,Daman Saluja
Scientific Reports.2020;10(1)1969
[DOI]
8Applicability of Chromatographic Co-Elution for Antibiotic Target Identification
Sina Schäkermann,Dominik Wüllner,Abdulkadir Yayci,Andrew Emili,Julia Elisabeth Bandow
PROTEOMICS.2021;21(1)2000038
[DOI]
9Mycobacterial protein tyrosine kinase, PtkA phosphorylates PtpA at tyrosine residues and the mechanism is stalled by the novel series of inhibitors
Swati Jaiswal,Aditi Chatterjee,Sapna Pandey,Kiran Lata,Ranjith Kumar Gadi,Rajesh Manda,Sanjay Kumar,Maddi Sridhar Reddy,Ravishankar Ramachandran,Kishore K. Srivastava
Journal of Drug Targeting.2019;27(1)51
[DOI]
10Strategies towards the synthesis of anti-tuberculosis drugs
Haridas B. Rode,Dhanaji M. Lade,René Grée,Prathama S. Mainkar,Srivari Chandrasekhar
Organic & Biomolecular Chemistry.2019;17(22)5428
[DOI]
11Impact of drug-resistant tuberculosis treatment on hearing function in South African adults: Bedaquiline versus kanamycin
Katijah Khoza-Shangase,Marina Prodromos
South African Journal of Communication Disorders.2021;68(1)5428
[DOI]
12Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations
Shalini Saxena,Maaged Abdullah,Dharmarajan Sriram,Lalitha Guruprasad
Journal of Biomolecular Structure and Dynamics.2018;36(12)3184
[DOI]
13Multitarget Approaches against Multiresistant Superbugs
Declan Alan Gray,Michaela Wenzel
ACS Infectious Diseases.2020;6(6)1346
[DOI]
14Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance
Vahid Lohrasbi,Malihe Talebi,Abed Zahedi Bialvaei,Lanfranco Fattorini,Michel Drancourt,Mohsen Heidary,Davood Darban-Sarokhalil
Tuberculosis.2018;109(6)17
[DOI]
15Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance
Fiona V. Cresswell,Abdu K. Musubire,Katarina M. Johansson Århem
Tuberculosis.2020;109(6)67
[DOI]
16Bedaquiline and delamanid in tuberculosis
Susanna Esposito,Sonia Bianchini,Francesco Blasi
Expert Opinion on Pharmacotherapy.2015;16(15)2319
[DOI]
17An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)
Mahanjit Konwar,MiteshR Maurya,TusharB Nishandar,UrmilaM Thatte,NithyaJ Gogtay
Perspectives in Clinical Research.2021;12(3)159
[DOI]
18A review of current and promising nontuberculous mycobacteria antibiotics
Christophe R Cantelli,Alexandra Dassonville-Klimpt,Pascal Sonnet
Future Medicinal Chemistry.2021;13(16)1367
[DOI]
19A structure-based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study
Linhu Li,Yuanyuan Jin,Bin Wang,Zhaoyong Yang,Mingliang Liu,Huiyuan Guo,Jun Zhang,Yu Lu
Chemical Biology & Drug Design.2018;91(3)769
[DOI]
20New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers
Serge Mignani,Rama Tripathi,Liang Chen,Anne-Marie Caminade,Xiangyang Shi,Jean-Pierre Majoral
Pharmaceutics.2018;10(3)105
[DOI]
21Two Decades of TB Drug Discovery Efforts—What Have We Learned?
Balachandra Bandodkar,Radha Krishan Shandil,Jagadeesh Bhat,Tanjore S. Balganesh
Applied Sciences.2020;10(16)5704
[DOI]
22Two Decades of TB Drug Discovery Efforts—What Have We Learned?
Corliss A. O’Bryan,Philip G. Crandall,Steven C. Ricke
Applied Sciences.2018;10(16)99
[DOI]
23Inhibition of Mycobacterium tuberculosis InhA: Design, synthesis and evaluation of new di-triclosan derivatives
Tom Armstrong,Malcolm Lamont,Alice Lanne,Luke J. Alderwick,Neil R. Thomas
Bioorganic & Medicinal Chemistry.2020;28(22)115744
[DOI]
24Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline
Tejal Rawal,Snehal Patel,Shital Butani
European Journal of Pharmaceutical Sciences.2018;124(22)273
[DOI]
25A Test System for in vitro Screening Antimycobacterial Drug Candidates for MmpS5-MmpL5 Mediated Resistance
K. V. Shur,S. G. Frolova,N. I. Akimova,V. N. Danilenko,D. A. Maslov
Russian Journal of Genetics.2021;57(1)114
[DOI]
26Bedaquiline: A Mini Review
Nandhini Saravanabavan,Padmavathi Shanmuganathan,Manimekalai Kumarappan
Annals of SBV.2020;8(1)2
[DOI]
27Synthesis, Characterization, Molecular Docking Studies and Biological Evaluation of Some Conjugated Quinazoline-Sulfonamide Scaffold
A. Sunil Kumar,Jyothi Kudva,B. R. Bharath,Vaishali M Rai,S. Madan Kumar,Vasantha Kumar,Shyama Prasad Sajankila
ChemistrySelect.2018;3(48)13586
[DOI]
28Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance
Mark Laws,Peiqin Jin,Khondaker Miraz Rahman
Trends in Microbiology.2021;3(48)13586
[DOI]
29Knowledge Gaps in the Understanding of Antimicrobial Resistance in Canada
Kayley D. McCubbin,R. Michele Anholt,Ellen de Jong,Jennifer A. Ida,Diego B. Nóbrega,John P. Kastelic,John M. Conly,Matthias Götte,Tim A. McAllister,Karin Orsel,Ian Lewis,Leland Jackson,Graham Plastow,Hans-Joachim Wieden,Kathy McCoy,Myles Leslie,Joan L. Robinson,Lorian Hardcastle,Aidan Hollis,Nicholas J. Ashbolt,Sylvia Checkley,Gregory J. Tyrrell,André G. Buret,Elissa Rennert-May,Ellen Goddard,Simon J. G. Otto,Herman W. Barkema
Frontiers in Public Health.2021;9(48)13586
[DOI]
30The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis
Rebecca C. Harris,Mishal S. Khan,Laura J. Martin,Victoria Allen,David A. J. Moore,Katherine Fielding,Louis Grandjean
BMC Infectious Diseases.2016;16(1)13586
[DOI]
31Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era
Alina Minias,Lidia Zukowska,Ewelina Lechowicz,Filip Gasior,Agnieszka Knast,Sabina Podlewska,Daria Zygala,Jaroslaw Dziadek
Frontiers in Microbiology.2021;11(1)13586
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow